• Home
    • Concept
  • Program
    • Scientific Board
    • Speakers
  • Abstracts
  • PneumoLive
  • Livestream
  • On-demand
  • Partners
  • Symposia
  • Venue
  • Registration
  • Contacts
    • Data Privacy Policy
    • Legal Notice
info@medupdate-europe.eu
Login

Login
Pneumo Update Europe 2022Pneumo Update Europe 2022
Pneumo Update Europe 2022
10 - 11 June - Vienna & Virtual
  • Home
    • Concept
  • Program
    • Scientific Board
    • Speakers
  • Abstracts
  • PneumoLive
  • Livestream
  • On-demand
  • Partners
  • Symposia
  • Venue
  • Registration
  • Contacts
    • Data Privacy Policy
    • Legal Notice

Partners

More Information

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Check here for more information about www.novartis.com

More Information

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

Check here for more information about www.sanofi.com

Watch past symposia here!

Type 2 inflammation: new developments in severe asthma management

Pneumology meets otorhinolaryngology

More Information

CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.

Check here for more information about www.cslbehring.com

Watch past symposia here!

Looking for the 'zebras' among the horses in common respiratory disorders: could it be something else?

Sharing important insights: what we learnt from Covid-19

More Information

Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Check here for more information about www.boehringer-ingelheim.com

In cooperation with
Submit an Abstract pay only 250€! Register Here

Accreditation – EACCME

The Pneumo Update Europe 2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 9 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Accreditation – EBAP

The European Board for Accreditation in Pneumology (EBAP) has found the PUE22 worthy of accreditation for 9 CME credits covering the whole program. EBAP reviewers have awarded the Mark of Excellence (MOE) for this activity which is worth an extra 3 CME credits. An MOE is given to activities with exceptionally high quality and standards.

Follow us

ethical medtech

www.ethicalmedtech.eu

© 2022

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}